Idexx Laboratories Inc /DeIDXX

NasdaqHealthcareIn Vitro & In Vivo Diagnostic Substances
Price (close)
$513.39
Market cap
$40.5B
P/E
35.5x
Revenue (TTM)
$4.6B
Net income
$1.1B
Dividend yield
—
1-year total return
-17.0%
Net margin
25.0%
Revenue growth
12.8%
Debt / equity
0.28x

What Idexx Laboratories Inc /De does.

IDEXX was incorporated in Delaware in 1983. We develop, manufacture, and distribute products and provide services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. We also manufacture and sell human medical point-of-care diagnostic products. Our primary products and services are:

• Health monitoring, biological materials testing, laboratory diagnostic instruments, and services used by the biomedical research community;

Our Purpose is to be a great company that creates exceptional long-term value for our customers, employees, and stockholders by enhancing the health and well-being of pets, people, and livestock.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$2.7B$3.2B$3.4B$3.7B$3.9B$4.3B
Net income$581.8M$744.8M$679.1M$845.0M$887.9M$1.1B
Free cash flow$541.1M$636.0M$394.1M$772.9M$808.1M$1.1B

More on IDXX.

Figures from Idexx Laboratories Inc /De's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.